Vascudyne, Inc.
Clinical trials sponsored by Vascudyne, Inc., explained in plain language.
-
Artificial artery tested in first 5 heart patients
Disease control ENROLLING_BY_INVITATIONThis early study tests a man-made blood vessel (called Vascudyne CAB A) in 5 people who need coronary artery bypass surgery for blocked heart arteries. The goal is to see if the graft stays open and safe, without causing major heart or brain events. This is not a cure; it aims to…
Phase: EARLY_PHASE1 • Sponsor: Vascudyne, Inc. • Aim: Disease control
Last updated May 17, 2026 14:09 UTC
-
Engineered blood vessels could change heart surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a new lab-made blood vessel (ATEV) for coronary bypass surgery in 20 people with multi-vessel heart disease. The goal is to see if it is safe and works well when used alongside standard bypass grafts. Participants will be followed for up to 12 months to check for…
Phase: NA • Sponsor: Vascudyne, Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC